Abstract
Objective: To analyze the clinical, social, and operational factors associated with the persistence of high tuberculosis rates in Brazil’s Federal District between 2013 and April 2025. Methods: This is an ecological study based on an integrative literature review. A total of 20 original articles published between 2013 and 2025 were included, selected from SciELO, Scopus, and PubMed databases, using thematic relevance, practical-theoretical scope, and methodological rigor as inclusion criteria. Articles were validated through dual reading and thematic analysis. Results: Findings indicate that the sustained tuberculosis burden in the Federal District stems from the intersection of social vulnerabilities (low income, limited schooling, household overcrowding), structural weaknesses, and operational barriers such as underreporting, low adherence to chemoprophylaxis, and disrupted epidemiological surveillance—worsened during the COVID-19 pandemic. Socioeconomic factors account for up to 70% of the variability in infection and mortality indicators. Conclusion: Tuberculosis in the Federal District represents a multifaceted structural crisis that transcends biomedical boundaries. The study underscores the urgency of integrated public policies that combine social protection, territorialized surveillance, expanded diagnostic coverage, and strengthened primary health care.
References
ALVES JD, et al. Determinantes sociais e impacto das desigualdades na mortalidade por tuberculose no Brasil: estudo ecológico em cinco regiões. Revista Brasileira de Epidemiologia, 2019; 22:190001.
ASARE-BAAH M, et al. Enhancing tuberculosis contact tracing through genotyping: a population-based study in low-incidence settings. International Journal of Tuberculosis and Lung Disease, 2025; 29(1): 23-32.
BRASIL. Boletim Epidemiológico – Tuberculose 2025. Disponível em: https://www.gov.br/aids/pt-br/central-de-conteudo/boletins-epidemiologicos/2025/boletim-epidemiologico-tuberculose-2025/view. Acessado em: 15 de março de 2025.
BRASIL. Cartilha ACS – Tuberculose: orientações para visita domiciliar e busca ativa. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/cartilha_agente_comunitario_saude_tuberculose.pdf. Acessado em: 17 de março de 2025.
BRASIL. Estratégia de Saúde Digital para o Brasil 2020–2028. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/estrategia_saude_digital_Brasil.pdf. Acessado em: 21 de março de 2025.
BRASIL. Guia de vigilância em saúde: Tuberculose. Disponível em: https://www.sjp.pr.gov.br/wp-content/uploads/2024/07/TUBERCULOSE-GUIA-DE-VIGILANCIA-EM-SAUDE.pdf. Acessado em: 20 de março de 2025.
BRASIL. Informativo Epidemiológico – Ano 08, nº 2, fevereiro de 2021. SES/DF. Disponível em: https://www.saude.df.gov.br/documents/37101/0/Informe+epidemiológico+TB_20+março+2021.pdf/6718b449-86f5-549f-f0d0-028d8208a2a7?t=1666354439909. Acessado em: 28 de março de 2025.
BRASIL. Linha de cuidado da tuberculose: orientações a gestores e profissionais de saúde. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/linha_cuidado_tuberculose_orientacoes_gestores_profissionais_saude.pdf. Acessado em: 14 de março de 2025.
BRASIL. Manual de recomendações para o controle da tuberculose no Brasil: 2ª edição. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/tuberculose/manual-de-recomendacoes-e-controle-da-tuberculose-no-brasil-2a-ed.pdf/view. Acessado em: 16 de março de 2025.
BRASIL. Nota Informativa nº 9/2024 – SES-SVS-DIVEP-GEVIST: Ampliação do uso do teste. Disponível em: https://www.saude.df.gov.br/documents/37101/0/SEI_148173790_Nota_Informativa_9.pdf/44bece88-adee-0bf0-1051-6266847bb363?t=1747916492774. Acessado em: 24 de março de 2025.
BRASIL. Programa Nacional de Controle da Tuberculose. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/ProgramaTB.pdf. Acessado em: 22 de março de 2025.
BRASIL. Registro de Sintomático Respiratório no Serviço de Saúde. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/registro_sintomatico_respiratorio
CHAN KPF, et al. Disruption of tuberculosis control by COVID-19 in Hong Kong: a time series analysis, 2018–2022. Clinical Infectious Diseases, 2024; 78(2): 456-463.
CHO SY, et al. Annual TB screening and preventive therapy among healthcare workers: impact on IGRA conversion and TB incidence. Journal of Hospital Infection, 2024; 139: 90-97.
CURY DB, et al. Risk of tuberculosis in patients with inflammatory bowel disease using anti-TNF agents: a 15-year cohort. Gut, 2024; 73(1): 45-53.
FARHAT M, et al. Challenges in the global management of multidrug-resistant tuberculosis: an updated review. Lancet Infectious Diseases, 2024; 24(5): 712-725.
GLASER L, et al. Seasonality and demographic determinants of tuberculosis transmission in the United Kingdom: analysis of 152,424 cases. Thorax, 2024; 79(3): 245-253.
GOLETTI D, et al. Recent advances in the pathogenesis and management of tuberculosis. Nature Reviews Disease Primers, 2023; 9: 45.
JONES-LÓPEZ EC, et al. Cough aerosols of Mycobacterium tuberculosis predict new infection: a household contact study. American Journal of Respiratory and Critical Care Medicine, 2014; 189(9): 1096-1104.
KIWANUKA N, et al. Community-based cohort study of latent tuberculosis infection incidence in Kampala, Uganda. PLOS ONE, 2024; 19(1): e0284557.
LIU Z, et al. Genomic epidemiology reveals recent transmission and hotspots of tuberculosis in Zhejiang Province, China. Emerging Infectious Diseases, 2024; 30(3): 512-522.
MACIEL EL, et al. Smoking and treatment outcomes in tuberculosis: a prospective cohort study. PLOS ONE, 2013; 8(5): e63229.
MADICO G, et al. Xpert MTB/RIF improves tuberculosis diagnosis in HIV-positive individuals with negative sputum cultures. Journal of Clinical Microbiology, 2016; 54(2): 367-371.
MATIAS GL, et al. Latent tuberculosis infection among household contacts: prevalence, treatment uptake, and completion rates. International Journal of Tuberculosis and Lung Disease, 2025; 29(4): 398-406.
MILLER AC, et al. Door-to-door active case finding of tuberculosis in a favela in Rio de Janeiro: effectiveness and challenges. International Journal of Tuberculosis and Lung Disease, 2010; 14(11): 1365-1371.
MÛLLER AM, et al. Effectiveness of educational interventions combined with tele-supervision to improve tuberculosis treatment adherence: a quasi-experimental study. BMC Infectious Diseases, 2019; 19(1): 791.
PEREIRA GR, et al. Implementation of Xpert MTB/RIF in a Brazilian urban setting: impact on diagnostic timeliness and drug resistance detection. Revista da Sociedade Brasileira de Medicina Tropical, 2018; 51(6): 800-807.
DOS SANTOS PCP, et al. Protective effect of BCG revaccination in adults exposed to tuberculosis: a randomized clinical trial. Vaccine, 2024; 42(12): 2201-2207.
VERZA M, et al. Whole genome sequencing uncovers multiple introductions and nosocomial transmission of Mycobacterium tuberculosis in Southern Brazil. Infection, Genetics and Evolution, 2020; 81: 104260.
ZAMPARELLI SS, et al. Global impact of COVID-19 on tuberculosis services: a modeling analysis. European Respiratory Journal, 2022; 59(6): 2102926.
